Anti-IPRI/ ITPRIP/ DANGER monoclonal antibody

Anti-IPRI/ ITPRIP/ DANGER antibody for FACS & in-vivo assay

Target products collectionGo to ITPRIP/ITPRIP products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP0643-Ab-1/ GM-Tg-hg-MP0643-Ab-2Anti-Human ITPRIP monoclonal antibodyHuman
GM-Tg-rg-MP0643-Ab-1/ GM-Tg-rg-MP0643-Ab-2Anti-Rat ITPRIP monoclonal antibodyRat
GM-Tg-mg-MP0643-Ab-1/ GM-Tg-mg-MP0643-Ab-2Anti-Mouse ITPRIP monoclonal antibodyMouse
GM-Tg-cynog-MP0643-Ab-1/ GM-Tg-cynog-MP0643-Ab-2Anti-Cynomolgus/ Rhesus macaque ITPRIP monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP0643-Ab-1/ GM-Tg-felg-MP0643-Ab-2Anti-Feline ITPRIP monoclonal antibodyFeline
GM-Tg-cang-MP0643-Ab-1/ GM-Tg-cang-MP0643-Ab-2Anti-Canine ITPRIP monoclonal antibodyCanine
GM-Tg-bovg-MP0643-Ab-1/ GM-Tg-bovg-MP0643-Ab-2Anti-Bovine ITPRIP monoclonal antibodyBovine
GM-Tg-equg-MP0643-Ab-1/ GM-Tg-equg-MP0643-Ab-2Anti-Equine ITPRIP monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP0643-Ab-1/ GM-Tg-hg-MP0643-Ab-2; GM-Tg-rg-MP0643-Ab-1/ GM-Tg-rg-MP0643-Ab-2;
GM-Tg-mg-MP0643-Ab-1/ GM-Tg-mg-MP0643-Ab-2; GM-Tg-cynog-MP0643-Ab-1/ GM-Tg-cynog-MP0643-Ab-2;
GM-Tg-felg-MP0643-Ab-1/ GM-Tg-felg-MP0643-Ab-2; GM-Tg-cang-MP0643-Ab-1/ GM-Tg-cang-MP0643-Ab-2;
GM-Tg-bovg-MP0643-Ab-1/ GM-Tg-bovg-MP0643-Ab-2; GM-Tg-equg-MP0643-Ab-1/ GM-Tg-equg-MP0643-Ab-2
Products NameAnti-ITPRIP monoclonal antibody
Formatmab
Target NameITPRIP
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-ITPRIP benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species IPRI/ ITPRIP/ DANGER VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-MP0643
    Target NameITPRIP
    Gene ID85450,414801,100912218,716246,609723,101090553,538685,100069597
    Gene Symbol and Synonyms4833424O12Rik,bA127L20,bA127L20.2,DANGER,ITPRIP,KIAA1754
    Uniprot AccessionQ8IWB1,A7MB64
    Uniprot Entry NameIPRI_HUMAN,IPRI_BOVIN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000148841
    Target ClassificationN/A

    The target: ITPRIP, gene name: ITPRIP, also named as DANGER, KIAA1754, bA127L20, bA127L20.2. This gene encodes a membrane-associated protein that binds the inositol 1,4,5-trisphosphate receptor (ITPR). The encoded protein enhances the sensitivity of ITPR to intracellular calcium signaling. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2012].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.